Skin of Color Update Virtual is the largest CE event dedicated to trending evidence-based research and new practical pearls for treating skin types III – VI. Attendees leave with critical annual updates and fresh practical pearls in skin of color dermatology. Earn CE virtually with direct access to elite experts and an experience unmatched by any other event in dermatology.
News & Research
A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Skin of Color Update
Skin of Color Update
Learn More
Discover case-based articles and lectures from this annual event.
View Now
The Latest
A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Hyperpigmentation Patients Report Low Satisfaction and Limited Awareness of Treatment Options A new cross-sectional survey reveals that hyperpigmentation, especially among patients with deeper skin tones, continues to be a significantly…
Curated by the JDD Editors Missed any of our July highlights? As the official partner of the Skin of Color Update , July is our “Bridging the Gap in Dermatology”…
Lotion or Cream? A Fresh Look at Moisturizer Efficacy in Dry Skin Dry skin is more than just a nuisance, it’s a clinical challenge that affects comfort, barrier function, and,…
Catch Up on July’s Latest Case Report on Pincer Nail Relief Pincer nail deformity isn’t just unsightly, it’s painful, persistent, and notoriously difficult to treat. While braces and surgery are…
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Featured Article Could vitiligo lower melanoma risk—or might it mask it? The intricate relationship between these conditions takes a surprising turn in this compelling case of melanoma on a non-sun-exposed site…
by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…
